IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.335
EU - Europa 1.233
AS - Asia 657
AF - Africa 113
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 4.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.221
IE - Irlanda 360
IT - Italia 355
CN - Cina 328
SG - Singapore 272
UA - Ucraina 162
CA - Canada 112
RU - Federazione Russa 100
CI - Costa d'Avorio 80
DE - Germania 53
SE - Svezia 35
IN - India 34
ES - Italia 33
CZ - Repubblica Ceca 28
SN - Senegal 26
GB - Regno Unito 24
FI - Finlandia 15
FR - Francia 15
BR - Brasile 11
CH - Svizzera 10
VN - Vietnam 9
AT - Austria 7
BE - Belgio 7
NG - Nigeria 7
GR - Grecia 6
LB - Libano 6
PL - Polonia 6
NL - Olanda 5
BG - Bulgaria 4
EU - Europa 4
JP - Giappone 4
SK - Slovacchia (Repubblica Slovacca) 3
UZ - Uzbekistan 3
AR - Argentina 1
AU - Australia 1
BO - Bolivia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
HU - Ungheria 1
IS - Islanda 1
MX - Messico 1
PT - Portogallo 1
PY - Paraguay 1
SM - San Marino 1
TR - Turchia 1
Totale 4.358
Salva come PNG Salva come JPEG
Città #
Santa Clara 446
Dublin 343
Chandler 304
Jacksonville 237
Singapore 191
Chicago 188
Boardman 140
Cambridge 93
Lawrence 93
Andover 91
Nanjing 87
Catania 86
Abidjan 80
Toronto 80
Des Moines 65
Houston 39
Civitanova Marche 35
Nanchang 32
Hebei 30
Messina 28
Ottawa 28
Dakar 26
Saint Petersburg 25
Hyderabad 22
Shenyang 22
Tianjin 22
Ashburn 21
Prague 21
Jiaxing 20
Changsha 19
San Mateo 19
Los Angeles 18
Wilmington 18
Barcelona 17
Rome 16
Munich 14
Zhengzhou 10
Jinan 9
Seattle 8
Abuja 7
Augusta 7
Beijing 7
Brussels 7
Dong Ket 7
Florence 7
Moscow 7
Berlin 6
Guangzhou 6
Helsinki 6
Lappeenranta 6
Madrid 6
Redwood City 6
Bremen 5
Foggia 5
Hangzhou 5
Ningbo 5
Tübingen 5
Falls Church 4
Grafing 4
Irvine 4
Mumbai 4
Reggio Calabria 4
Shanghai 4
Vicenza 4
Bolzano 3
Cork 3
Den Haag 3
Espoo 3
Frankfurt Am Main 3
Kunming 3
Liberty Lake 3
Norwalk 3
Taizhou 3
Tappahannock 3
Washington 3
Aci Catena 2
Amiens 2
Amsterdam 2
Avola 2
Cerdanyola del Vallès 2
Fuzhou 2
Hanoi 2
Krakow 2
Leawood 2
London 2
Ludwigshafen 2
Maletto 2
Mazara del Vallo 2
Naples 2
Novokuznetsk 2
Pune 2
Riposto 2
Sereg 2
Sesto Fiorentino 2
Springfield 2
Stockholm 2
Tokyo 2
Vienna 2
Ann Arbor 1
Asunción 1
Totale 3.262
Salva come PNG Salva come JPEG
Nome #
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 86
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 75
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 74
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 73
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 73
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 72
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 71
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 69
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 69
Altro che Marijuana i molteplici ruoli delle sostanze cannabinoidi endogene 68
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 65
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 62
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 62
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 61
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 58
Endocannabinoids and neurodegenerative diseases 57
Attuali orientamenti terapeutici della malattia di Parkinson 56
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 56
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 56
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 56
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 56
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 53
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 53
Behavioral modifications induced by dietary cholesterol in rats 53
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 52
Fluoxetine Protects Retinal Ischemic Damage in Mice 51
Therapeutic potential of cannabinoids in schizophrenia 51
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 50
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 50
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 49
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 49
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 48
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 47
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 47
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 47
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 47
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 47
Effects of citalopram combined with memantine in forced swimming test in rats 45
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 45
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 44
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 44
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 43
Parkin expression profile in dopamine d3 receptor knock-out mice brains 43
Endocannabinoid system genes regulation in schizophrenia 43
Dual effects of melatonin on barbiturate-induced narcosis in rats 43
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 43
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 43
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 42
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 42
The amnesic effects induced by ßamyloid fragment 1-42 involve cannabinoid neurotransmission in the brain 42
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 42
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 42
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 41
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 41
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 41
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 40
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 40
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 40
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 39
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 39
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 39
Vitamin D and depression in women: a mini-review 38
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 37
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 37
Prolonged fear incubation leads to generalized avoidance behavior in mice 37
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 37
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 37
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 37
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 36
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 35
Endocannabinoid system and mood disorders: Priming a target for new therapies 35
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 35
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 35
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 35
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 35
Dynamic DNA methylation programs persistent adverse effects of early-life stress 34
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 33
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 33
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 33
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 33
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 33
Olanzapine, but not haloperiool, improves cognitive performance in an animal model of amnesia induced by β-amyloid peptides 32
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 32
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 32
Endocannabinoid system, stress and HPA axis 32
Hippocampal expression of BDNF is involved in the behavioral effects of the β3 adrenoceptor agonist, SR58611A 31
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 31
Leading compounds for the validation of animal models of psychopathology 31
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 31
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 31
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 30
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 29
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice 28
D3 dopamine receptor knockout mice tested in the forced swim test: increased sensitivity to different antidepressant drugs 27
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 26
Parkin expression in dopamine D3 receptor Knock out mice 26
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation 26
NK 2 receptor: A new target for depression therapy 24
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 22
Cannabidiol and the central nervous system: translating into clinics 21
Totale 4.422
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.242
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020186 0 0 0 0 0 18 37 1 22 2 76 30
2020/2021386 8 22 47 1 136 9 64 6 22 7 44 20
2021/2022668 92 90 7 23 100 11 96 35 33 2 12 167
2022/20231.058 98 51 12 85 87 188 10 185 263 3 42 34
2023/2024446 32 67 26 32 18 53 4 14 34 17 92 57
2024/20251.193 30 336 127 119 580 1 0 0 0 0 0 0
Totale 4.543